 |
CD33-directed antibody-drug conjugate consisting of an antibody conjugated to a DNA cross-linking pyrrolobenzodiazepine dimer drug |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukaemia |
| EU Market Approval | EU |
| EU Designation Date | 2015-08-10 00:00:00 |
| Sponsor | Seattle Genetics UK, Limited |
